Translation, cross-cultural adaptation and validation of questionnaires for Turkish and Moroccan Dutch patients with mood, anxiety and/or somatoform disorders and a comparison between native Dutch and Turkish and Moroccan immigrant patients

Translation, cross-cultural adaptation and validation of questionnaires for Turkish and Moroccan Dutch patients with mood, anxiety and/or somatoform disorders and a comparison between native Dutch and Turkish and Moroccan immigrant patients - Leiden Routine Outcome Monitoring Study for Moroccan and Turkish immigrants

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41543

Enrollment

570

Registered

2012-04-23

Start date

2012-08-15

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angst- en somatoforme stoornissen affective symptoms anxiety symptoms mood somatic symptoms

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For the pilot- and validation study:* Patients and healthy participants eligible for this study are: (1) those who have moderate mood, anxiety and/or somatoform (MAS) symptoms (applies only to patients); (2) those who are born in Turkey or Morocco or have at least one parent or a grandparent born in Turkey or Morocco; (3) between 18 and 65 years old; and (4) proficient in the Moroccan Arabic, Tarifit or Turkish language.** All Moroccan and Turkish patients who are referred for treatment of mood, anxiety and/or somatoform (MAS) symptoms to Rivierduinen, RIAGG Rijdmond or i-psy Amsterdam will be approached to participate in this research, whether or not they are diagnosed with a MAS disorder.** ;For focus groups:* Healthy participants eligible for this study are: (1) those who are born in Turkey or Morocco or have at least one parent or a grandparent born in Turkey or Morocco; (2) between 18 and 65 years old; (3) proficient in the Moroccan Arabic, Tarifit or Turkish language; and (4) proficient in the Dutch language.;For comparative study:* Patients eligible for this study are: (1) between 18 and 65 years old; (2) have a Dutch, Moroccan or Turkish ethnic background; (3) proficient in the Dutch, the Moroccan Arabic, Tarifit, or Turkish language; and (4) referred for MAS symptoms to Rivierduinen, RIAGG Rijnmond, or i-psy Amsterdam, whether or not they are diagnosed with a MAS disorder.

Exclusion criteria

Exclusion criteria: For the pilot- and validation study*: The following patients are excluded: (1) patients who have insufficient proficiency in the Moroccan Arabic, Tarifit or Turkish language; (2) patients with a primary psychiatric disorder other than a mood, anxiety and/or somatoform disorder; (3) with severe psychiatric problems; (4) patients with suicidal ideations; or (5) patients who display major impairment in social functioning.;The following healthy participants are excluded: who have insufficient proficiency in the Moroccan Arabic, Tarifit or Turkish language.;For focus groups: There are no exclusion criteria.**;For comparative research:* The following patients are excluded: (1) Patients with a primary psychiatric disorder other than a mood, anxiety and/or somatoform disorder; (2) patients with severe psychiatric problems; (3) patients with suicidal ideations; or (4) patients who display major impairment in social functioning.

Countries

Netherlands

Outcome results